Inhibition of leucocytic lysosomal enzymes by glycosaminoglycans in vitro.
about
Sanfilippo syndrome: causes, consequences, and treatmentsNeurobiology and cellular pathogenesis of glycolipid storage diseases.Secondary lipid accumulation in lysosomal disease.New roles of glycosaminoglycans in α-synuclein aggregation in a cellular model of Parkinson disease.Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.Insoluble low-density lipoprotein-proteoglycan complexes enhance cholesteryl ester accumulation in macrophagesThe pathology of the feline model of mucopolysaccharidosis VI.The mucopolysaccharidoses: a success of molecular medicine.Lessons learnt from animal models: pathophysiology of neuropathic lysosomal storage disorders.Neuraminidase inhibition by chemically sulphated glycopeptides.Physicochemical characteristics of the glycosaminoglycan-lysosomal enzyme interaction in vitro. A model of control of leucocytic lysosomal activity.Cationic polyelectrolytes: a new look at their possible roles as opsonins, as stimulators of respiratory burst in leukocytes, in bacteriolysis, and as modulators of immune-complex diseases (a review hypothesis).Rheological properties of hyaluronic acid and its effects on salivary enzymes and candida.The half-life of human procathepsin S.Cysteine cathepsin activity regulation by glycosaminoglycans.The influence of the type of sulphate bond and degree of sulphation of glycosaminoglycans on their interaction with lysosomal enzymes.Studies on a molecular basis for the heparin-induced regulation of enzymatic activity of mouse striatal tyrosine hydroxylase in vitro. Inhibition of heparin activation and of the enzyme by poly-L-lysyltyrosine and poly-L-lysylphenylalanine and theirHydrodynamic properties of connective-tissue polysaccharidesNumerous transcriptional alterations in liver persist after short-term enzyme-replacement therapy in a murine model of mucopolysaccharidosis type VII.Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders.Glycosaminoglycans modulate activation, activity, and stability of tripeptidyl-peptidase I in vitro and in vivo.Abnormal neuronal metabolism and storage in mucopolysaccharidosis type VI (Maroteaux-Lamy) disease.Molecular weight distribution of hyaluronic acid of human synovial fluid in rheumatic diseases.Enzyme-replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type IIIA mice.Insights on a new path of pre-mitochondrial apoptosis regulation by a glycosaminoglycan mimetic.Live Cell Imaging and Profiling of Cysteine Cathepsin Activity Using a Quenched Activity-Based Probe.Pathology of Mucopolysaccharidosis IIIA in Huntaway DogsCathepsin B secretion by rabbit articular chondrocytes: modulation by cycloheximide and glycosaminoglycans
P2860
Q26773200-3AB6F88D-7119-49F9-843D-0E91A9E7253FQ35153227-8541AAF4-5136-41E1-8B7B-FDD9ABE923C0Q35240940-D420F95B-4284-45B0-B2D4-34E4DCD50335Q35548527-F6986977-90A2-4F51-AC8F-BE07BA3DBCEBQ35811925-7AB9FEB2-9DD1-4725-88D4-8F1B619BB14BQ35835281-9EC9BE1B-35B6-491E-981C-A2F06310C318Q35863589-E9B3C5BD-E147-4EDA-9F4F-FF7687CF00B6Q37059193-48E0DF2E-D7C8-4D1B-AB18-3B3212A0C988Q37744753-B5B6ADF6-16DD-4692-87D6-E67A3E3AD053Q38357496-5848B4CD-7395-40D6-9D67-792FE7FDDBF6Q39129988-4C6FA9B4-9EFA-42FF-8168-C6A8BB54C1A9Q39484244-4D4117C8-BFB4-419A-ACB0-F2E7169F3A63Q39924286-066E2A47-7256-4131-BEE2-BC59877CFBF1Q40932134-A1058C91-95DD-40A5-9D71-21CB8C3E83F8Q41852264-6E0BE9DB-1051-46D8-8EB2-14B3843B2A73Q42169898-F855BDC1-8614-4A88-A8C7-15FDC4940A65Q42241037-B1B32F36-CA2C-4AA1-8515-D55C1D152892Q42794806-C3DF2E99-36B2-4FDC-A19F-5EE4C94503CBQ43003656-48E621E9-5493-4A9A-93E5-8851CCE32B51Q45159507-8523084E-1EB6-4EB0-8D4D-B170263B1BDCQ45176585-35EB442F-9B21-4922-8576-293335557E0AQ46692908-47E5633E-8F25-4E93-8895-2837F1F6CE30Q47260185-9A95ABB0-4D31-4438-BC9A-51143BEC3800Q47643319-87C773E6-A38C-4653-85E6-A5739B08801AQ51811662-DEB6F589-B440-4081-B044-005D543BD490Q52864120-F05C5527-4841-41EE-B440-08D1FB3DC224Q56657678-34B4E47D-E56C-4362-83C4-9A4B974D16B9Q57696132-213B4596-B7A7-4C0E-95BF-4C96B24ABE4D
P2860
Inhibition of leucocytic lysosomal enzymes by glycosaminoglycans in vitro.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Inhibition of leucocytic lysosomal enzymes by glycosaminoglycans in vitro.
@en
Inhibition of leucocytic lysosomal enzymes by glycosaminoglycans in vitro.
@nl
type
label
Inhibition of leucocytic lysosomal enzymes by glycosaminoglycans in vitro.
@en
Inhibition of leucocytic lysosomal enzymes by glycosaminoglycans in vitro.
@nl
prefLabel
Inhibition of leucocytic lysosomal enzymes by glycosaminoglycans in vitro.
@en
Inhibition of leucocytic lysosomal enzymes by glycosaminoglycans in vitro.
@nl
P2860
P356
P1433
P1476
Inhibition of leucocytic lysosomal enzymes by glycosaminoglycans in vitro.
@en
P2093
P2860
P356
10.1042/BJ1520057
P407
P577
1975-10-01T00:00:00Z